Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
Published on: September 8, 2023
The Reduction of COMP Serves as a Predictor for Warning of Aortic Dissection Progression
Zhuofan Li1, Ze Gong2, Weihao Li3
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
Insights
Reduced cartilage oligomeric matrix protein (COMP) in plasma may indicate thoracic aortic dissection (TAD) progression. COMP appears to protect against TAD development and vascular damage, suggesting its potential as a novel biomarker.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Vascular Biology
Background:
- Thoracic aortic dissection (TAD) is a critical cardiovascular condition with high mortality rates.
- Current diagnostic and monitoring methods for TAD lack novel biomarkers.
- Identifying new biomarkers is crucial for improving TAD patient outcomes.
Purpose of the Study:
- To investigate cartilage oligomeric matrix protein (COMP) as a potential biomarker for thoracic aortic dissection (TAD).
- To evaluate the role of COMP in the pathogenesis and progression of TAD.
- To explore COMP's therapeutic potential in preventing or mitigating TAD.
Main Methods:
- A case-control study involving 362 TAD patients and 136 controls was conducted.
- Plasma COMP levels were measured and analyzed to identify significant differences.
- The protective function of COMP was further examined using two distinct mouse models of TAD.
Main Results:
- A significant and sustained decrease in plasma COMP levels was observed in TAD patients compared to controls.
- Experimental models demonstrated that COMP can suppress TAD development.
- COMP was found to ameliorate vascular pathogenesis associated with TAD.
Conclusions:
- Decreased plasma COMP levels may serve as a novel and valuable biomarker for monitoring TAD progression.
- COMP exhibits a protective role against the development of TAD.
- COMP has the potential to be a therapeutic target for mitigating vascular damage in TAD.
Abstract:
Thoracic aortic dissection (TAD) is a life-threatening cardiovascular disease that is associated with high morbidity and mortality. The prevailing challenge in TAD monitoring and diagnosis is the lack of novel biomarkers. A significant and sustained reduction in plasma cartilage oligomeric matrix protein (COMP) levels was observed through a case control analysis conducted in 362 TAD patients and 136 controls. The protective role of COMP was assessed in two TAD mouse models. These data suggested that a decreased plasma COMP level might serve as a novel biomarker for TAD progression and COMP could suppress the development of TAD and ameliorate vascular pathogenesis.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation III: Medical Management

